Author:
Kravchun N.O., ,Dunaieva I.P.,Yakovenko O.L.,Kravchun P.P., , ,
Abstract
The comorbidity of arterial hypertension (AH), type 2 diabetes mellitus (T2DM), obesity leads to the early development of atherosclerotic lesions of coronary and cerebral vessels, which, in turn, significantly accelerates the occurrence of coronary arterial disease (CHD), vascular disasters, namely, myocardial infarction (MI), stroke. Comorbidity fully refers to the concept of “metabolic syndrome”. By definition, metabolic syndrome (MS) is a complex of interrelated clinical, metabolic and hormonal disorders caused by the dysregulation of various genes, the influence of external environmental factors, associated with increased cardiovascular risk, and an increase in overall mortality. The article is intended to review modern scientific literature on metabolic syndrome and comorbid conditions associated with it.
Publisher
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
Reference34 articles.
1. 1. Karki R, Kodamullil A, Hofmann-Apitius M. Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs. Journal of Alzheimer's Disease. 2017;60(2):721-731. http://dx.doi.org/10.3233/jad-170440
2. 2. Edward Anyasodor A, Uba Nwose E, Stuart Richards R, Taderera Bwititi P, Awharentomah Digban K, Itietie Mudiaga L, Aganbi E, Ojodeme O. Co-morbidity of Diabetes Mellitus and Orodental Diseases in Nigeria. Current Diabetes Reviews. 2017;13(3):289-299. http://dx.doi.org/10.2174/1573399812666160413114146
3. 3. Mohilnytska LA. Kontsentratsiia vaskuloendotelialnoho faktoru rostu v syrovattsi krovi khvorykh z arterialnoiu hipertenziieiu, shcho suprovodzhuietsia tsukrovym diabetom 2 typu, ozhyrinniam. Visnyk problem biolohii i medytsyny 2017;4(141):158-163. doi: 10.29254/2077-4214-2017-4-3- 141-158-163. Ukrainian
4. 4. Liashuk RP, Liashuk PM. Metabolichnyi syndrom yak mizhdystsyplinarna problema (ohliad literatury). Mizhnarodnyi endokrynolohichnyi zhurnal 2017. tom 13 (7). doi: 10.22141/2224-0721.13.7.2017.115748; 43-46. Ukrainian
5. 5. McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clinics in Dermatology. 2018;36(1):14-20. http://dx.doi.org/10.1016/j.clindermatol.2017.09.004